UC Researches Depression in Women
With women twice as likely to suffer from depression as men, researchers continue to ask why they are so vulnerable and to seek new medications to treat the widespread problem.
Researchers at the UC Medical Center Women's Health Research Program, one of few groups in the country that focus on causes and treatments of disorders that predominately affect women, are investigating a new medication that shows promise in alleviating the effects of depression.
Women suffering from depression are invited to participate in the study, during which they will receive free study-related medication and evaluations.
Typical symptoms of depression include feeling sad or down, losing interest in usual activities, feelings of guilt, worthlessness, or hopelessness, and sleeplessness or lack of energy.
Lesley M. Arnold, MD, director of the Women's Health Research Program, says although it's not certain why women are more prone to depression than men, there is some evidence of a genetic link.
Dr. Arnold, an associate professor of psychiatry, says women "may inherit a propensity to become depressed in response to stress."
There's also evidence, Dr. Arnold says, that healthy women produce less serotonin, an important neurotransmitter involved in mood regulation, than men.
"We suspect that stress depletes serotonin," Dr. Arnold says, "so if you start with lower levels, as women do, serotonin could be depleted more easily, making women more susceptible to depression."
Depression is just one of the program's research interests. Investigators are also studying fibromyalgia, a chronic pain condition that is much more common in women than in men. Fibromyalgia is associated with fatigue, sleep disturbance and several other symptoms.
UC's Women's Health Research Program is a national leader in fibromyalgia research and has an ongoing fibromyalgia clinical trial and a genetic study.
Women interested in participating in the depression or fibromyalgia studies are invited to call 513-558-WHRP for more information. All inquiries will be confidential.
Tags
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.